Idea / market signal
What repeated buyer problem, channel opening, relationship edge or operating loop is visible?
Evidence-backed market signal with buyer, field and observed consequence.
DV Labs turns market signals into canonical venture records, prioritizes them from evidence-linked facts, executes 30/60/90 Proof Cells, then compiles measured external-cost evidence before a human can set any transaction-specific capital request.
Reusable engines, schemas, methods, workflow primitives and generalized operating machinery stay with DV Labs.
Brand, customers, vertical product, contracts and specifically defined venture assets can sit inside the new company.
New money is concentrated on distribution, customer acquisition, strategic hires, domain access and market-specific scale.
Working product, paid evidence and repeatability come before larger capital commitments or physical expansion.
The factory starts with a real market signal, selects the smallest authoritative DV system stack, defines the capital that cannot be replaced by retained machinery, then advances through proof, telemetry and stage-gated expansion.
What repeated buyer problem, channel opening, relationship edge or operating loop is visible?
Evidence-backed market signal with buyer, field and observed consequence.
Why is this a distinct economic vehicle instead of a feature, deployment or white-label branch?
Independent buyer, economics, field, distribution and risk thesis.
Which retained engines, genes and reusable systems can be licensed instead of rebuilt?
Ancestor products, parent engines, inherited genes and parent-reserved assets.
What is the smallest complete vertical product capable of producing real proof?
Bounded MVP scope, exclusions, authoritative systems and 30-day working-product target.
Which costs cannot be satisfied by retained DV machinery and therefore genuinely require new capital?
Proof-cell budget logic, external expense categories and post-proof capital corridor.
What must be proven before another layer of capital or scope is unlocked?
Working product → paid evidence → repeatability decision.
How does this vehicle earn its first dollar and later support an independent P&L?
First revenue path, primary model, expansion model and P&L independence test.
What does DV retain, what does the NewCo own, what is licensed, and what improvements flow back?
Explicit retained-IP, NewCo-IP, license, profit-participation, operating-control and optional exit structure.
What can be shown publicly, what requires protected diligence, and what formation trigger is still missing?
Opportunity Brief + proof packet + diligence list + formation trigger.
Which buyer, market and distribution path gets the first bounded deployment?
Named first market, first buyer archetype and launch motion.
Which signals determine whether the vehicle is working rather than merely active?
Acquisition, activation, retention, economics and delivery telemetry.
What evidence unlocks another field, product, capital stage, acquisition path or full spinout?
Stage-gated market, product, capital and exit expansion plan.
The formation gate is intentionally stricter than “good idea.” A serious NewCo/Twin candidate must pass at least four of seven separation tests; otherwise DV should use a deployment, license, white-label branch or product edition instead.
Formation engine JSONThe operating vehicle can own its market-facing business without automatically receiving every reusable engine that helped create it. Rights are divided deliberately so one product-level transaction does not silently sell the future descendants of the same machinery.
NewCo operating control and governance are transaction-specific; the default architecture keeps DV parent ownership of retained platform IP while the operating vehicle owns or controls its market-specific business assets.
Field of use, territory, term, sublicensing, brand, support and improvement rights are explicitly bounded.
Equity, capped revenue participation, license fees, implementation fees, support/Evolution, or another negotiated economic structure may be used; no single participation model is automatic.
A licensed operating NewCo can remain in the ecosystem, enter a field-specific JV, spin out under a continuing license, or be strategically acquired without automatically transferring the parent core.
Recombination rule: Successful generalized improvements should strengthen the retained DV estate without transferring NewCo confidential data, customer-specific material or third-party restricted assets. Final equity, license, revenue participation, governance, tax and acquisition terms remain transaction-specific and require explicit documentation.
These are not three inventions from zero. Each example starts from existing DV products or reusable engines, then identifies the external capital, buyer proof and operating work that still must be earned.
Operators lose time and trust when readiness, handoffs, evidence, blockers and customer-facing status are scattered across disconnected tools.
1–2 repeatable vertical wedges with paid evidence.
Teams cannot reliably show what changed, what was checked, what regressed and what evidence supports release claims.
Commercial pilot batches plus reliable connected runner.
Studios often split consultations, booking, deposits, artist calendars, client records and follow-up across disconnected tools.
Paid multi-studio proof.
Capital corridors shown above are internal planning hypotheses carried forward from the NewCo Atlas, not valuations, forecasts, fundraising recommendations or offers to sell securities.
The current ProofLayer Product NewCo has been compiled from a canonical NewCoCandidate into an investor-facing package with architecture, capital use, 30/60/90 proof gates, risks, IP boundaries, Q&A, a data-room manifest, and one clear next action.
The compiler deliberately leaves unsupported traction, unit economics, capital amount, valuation, and investor terms unclaimed rather than filling them with optimistic assumptions.
Determine whether the investor/strategic partner can materially accelerate the proof cell through commercial-pilot access, enterprise integration/security capability, or distribution—not simply provide undifferentiated capital.
A qualified investor can move from public package to scoped protected diligence, a controlled deal room, questions, proof requests, follow-up, term discussion, and a documented pass / commit state.
A Capital Gate records diligence progress; it is not itself a securities offer, subscription agreement, commitment document, valuation, return forecast, or transfer of DV Labs intellectual property.
DV separates evidence-backed facts from founder assumptions, then applies internal scenario weights to decide which venture should be built, validated, partnered, capitalized or held. The public surface shows the evidence boundary and current action without publishing the private weighting genome.
Exact scenario weights, confidence adjustments and internal scoring calculations remain inside Nexus. Public output shows the current evidence boundary, portfolio action and selected next diligence target without exposing the private prioritization genome.
Product, deployment and checkout infrastructure already exist. The next proof cell should measure commercial behavior rather than rebuild the software.
APP_STORE_PORTFOLIO_REGISTRY.md · billing-gateway/catalog.mjs · billing-gateway/README.md · github:Xinblack/automnemo/src/routes/index.tsx · github:Xinblack/automnemo/README.md
The larger unresolved variable is studio distribution, not core DV product capability. Prioritize a partner that can produce a real paid studio cohort.
src/data/projects.ts · APP_STORE_PORTFOLIO_REGISTRY.md · docs/newco/NEWCO_FACTORY_V2.md · src/data/newcoFactory.ts
Run a bounded paid-usage and vehicle-fit test before opening a separate NewCo diligence process.
src/data/catalogRecent.ts · APP_STORE_PORTFOLIO_REGISTRY.md
Ordinary diligence selection is already complete. The next useful step is a strategically qualified capital / distribution conversation against the existing Capital Gate.
src/data/newcoDiligence.ts · docs/newco/NEWCO_DILIGENCE_V3.md · docs/newco/NEWCO_CAPITAL_GATE_V4.md · src/data/newcoCapitalGate.ts · src/data/projects.ts
The umbrella vehicle is broader than current family-level commercial proof. Prove one vertical wedge before spending more formation or diligence effort on the family company.
docs/newco/NEWCO_FACTORY_V2.md · src/data/newcoFactory.ts
It is the current highest-priority non-HOLD candidate that does not already have an active Capital Gate, while product, deployment and checkout evidence already exist.
Next action: Compile AutoMnemo into NewCoCandidate v3; keep customer count, revenue, retention, CAC, margin and capital amount unknown until measured; generate the next scoped diligence package around paid-user behavior, acquisition, retention, support/native-release burden and partner distribution.
These are DV internal portfolio-allocation states surfaced for transparency. They are not valuations, return forecasts, investment recommendations, or claims that the first-ranked candidate will become the largest company.
v7 turns a portfolio action into a 30/60/90 operating cell with explicit evidence requirements, unsized external-spend categories, human approvals and stop/advance gates. Elapsed time is not treated as proof.
Use the already-built product in a measurable buyer-facing test. Verify acquisition, onboarding and the critical workflow instead of rebuilding the core.
Replace founder assumptions with paid-user, paid-pilot, activation and support-burden evidence.
Measure repeat use, channel leverage, delivery burden and economics strongly enough to decide advance, iterate, partner, hold or stop.
Product, deployment and checkout infrastructure already exist. The next proof cell should measure commercial behavior rather than rebuild the software.
Proof Cell v7 is an execution layer, not a fundraising promise. Customer counts, revenue, CAC, margin, retention, capital amounts and completion remain unknown until authoritative evidence exists.
Proof Cell schemav8 sits between commercial proof and transaction-specific capital work. It converts measured external costs into a baseline, keeps unknown categories unsized, and requires a human rationale before any requested-capital number can move into diligence.
Working product, paid evidence and repeatability inputs are recorded before capital sizing begins.
Quoted, approved or spent external categories become the observed cost baseline. Unsized categories remain visible blockers.
A requested external-capital amount is entered deliberately with a written use-of-funds rationale. No multiplier or return model is generated automatically.
Only after evidence and human review does the worksheet become eligible for transaction-specific diligence or Capital Gate terms.
The measured baseline is not a valuation, financing recommendation, runway forecast or securities offer. Any actual capital amount, terms, ownership, licensing or investor participation remains an explicit human and transaction-specific decision.
Capital Evidence schemaThe Opportunity Brief is not another pitch-deck template. It is the canonical formation record used to decide whether an idea should stay in the parent, become a deployment/license, or move toward a separately financed vehicle.
The compiler does not silently invent missing economics, buyer evidence or rights. It returns blocking gaps and warnings, scores the seven-test formation screen, and only treats a vehicle as formation-ready when the required decision fields are present.
The pathway is designed for strategic capital partners who can add market access, customers, compliance, distribution, operator capacity or physical expansion in addition to capital.
Review the NewCo model, company facts, proof and retained-IP architecture.
Inspect buyer, MVP, capital need, 30/60/90 proof plan, revenue model, rights and formation trigger.
Request only the architecture, economics, customer evidence or code material to the decision.
Select deployment, license, Product NewCo, Family NewCo, Twin, JV, SPV or parent-level route with counsel.
Fund the external capital needs required to reach working product, paid evidence and repeatability.
Use operating evidence to decide whether to scale, license another field, raise another stage, acquire or spin out.
Public material establishes the thesis; deeper architecture, economics, customer evidence and transaction structure remain purpose-gated. Viewing this page does not create an NDA, license, investment commitment or transfer of DV IP.
The useful next step is not a larger pitch deck. It is a narrower decision surface: what is already visible, what genuinely needs protected review, and which assumptions determine whether a specific NewCo should advance.
DV does not use this packet to predict returns or rank investor choices. The diligence path is designed to expose the evidence, assumptions, rights boundaries and next proof gate so each party can make its own decision.
Request scoped diligencePublic materials explain the venture-creation model without exposing source code, private weighting logic, credentials or detailed proprietary implementation. Deeper technical and economic diligence begins only after explicit agreement to the applicable confidentiality and use restrictions.
Receipt or viewing of this webpage alone does not create an NDA, non-compete or non-circumvention obligation.